A commercially available preparation of Staphylococcus aureus bio‐products potently inhibits tumour growth in a murine model of mesothelioma

Background and objective Mesothelioma is an incurable cancer with a rising global incidence. Intrapleural delivery of a commercially available compound made up of proteins produced by S taphylococcus aureus has been used clinically to induce pleurodesis. We investigate if this bacterial compound has anti‐tumoural activities against pleural malignancies, in addition to its pleurodesing effect. Methods The effects of the treatment on mesothelioma...